Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Uterine Cervical Neoplasms 1Papillomavirus Infections 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 8Peripheral Blood Stem Cell Transplantation 7Busulfan 6Antilymphocyte Serum 6fludarabine phosphate 5Methylprednisolone 4Methotrexate 4Filgrastim 4Cyclosporine 4Psychiatric Rehabilitation 3Whole-Body Irradiation 2Therapeutics 2Tacrolimus 2Radiotherapy 2Mycophenolic Acid 2Melphalan 2Etoposide 2Blood Specimen Collection 2Aprepitant 2fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1Ultraviolet Therapy 1Thiotepa 1Thalidomide 1Tai Ji 1Surveys and Questionnaires 1Restraint, Physical 1Resistance Training 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasms, Plasma Cell × Electronic Health Records × Clear all
NCT02356549 2020-04-01

African American Cancer Clinical Trial Decisions: Testing Tailored Messages

Virginia Commonwealth University

Phase NA Completed
90 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡